On August 27, 2025 AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, reported that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences (Press release, AnaptysBio, AUG 27, 2025, View Source [SID1234655507]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Global Healthcare Conference 2025, New York, NY

Format – Fireside chat and one-on-one investor meetings
Date and Time – Wednesday, Sept. 3, 2025 at 8:00am ET / 5:00am PT
2025 Wells Fargo Healthcare Conference, Boston, MA

Format – Fireside chat and one-on-one investor meetings
Date and Time – Thursday, Sept. 4, 2025 at 11:00am ET / 8:00am PT
Stifel 2025 Virtual Immunology and Inflammation Forum, Virtual

Format – Fireside chat and one-on-one investor meetings
Date and Time – Tuesday, Sept. 16, 2025 at 12:00pm ET / 9:00am PT
Live webcasts of the fireside chats will be available on the investor section of the Anaptys website at View Source Replays of the webcasts will be available for at least 30 days following the events.